Skip to content

A randomized controlled double-blind study for transcranial direct current stimulation in the treatment of postpartum depression

A randomized controlled double-blind study for transcranial direct current stimulation in the treatment of postpartum depression

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029031
Enrollment
Unknown
Registered
2020-01-11
Start date
2020-01-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postpartum depression

Interventions

Intervention Group:Transcranial direct current stimulation (anodic) and routine treatment
Control Group:Transcranial direct current stimulation (pseudostimulation) and routine treatment.

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Meet the criteria for classification and diagnosis of mental disorders in China (CCMD-III); 2. Top 17 items of the Hamilton Depression Scale >= 18; 3. Exclude history of severe somatic diseases, brain organ venereal diseases, drug dependence, no severe suicidal tendencies; 4. Pregnant women between 14 and 32 weeks of pregnancy (18 years or older) who have been provided but who have refused to use antidepressants during pregnancy; 5. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. alcohol or substance use barrier in the first 6 months; 2. history of major or unstable medical or neurological disorders or epilepsy; 3. There are metal implants in the body, such as pacemakers; 4. benzodiazepines were used (except for intermittent use of low-dose lorazepam) or anticonvulsant agents (these interfered with anodic tdcs; 5. Scalp irritation site with skin breakage; 6. preterm birth (gestational <32 weeks); 7. Current fetal abnormalities or major obstetric complications.

Design outcomes

Primary

MeasureTime frame
Self anxiety scale, SAS;self depression scale, SDS;Hamilton's Depression Scale, HAMD;Montgomery Asperger Depression Scale;Remission rate;MBI;

Countries

China

Contacts

Public ContactWeiming Sun

Department of Rehabilitation Medicine, The First Affiliated Hospital of Nanchang University

sunweiming08@126.com+86 13291419434

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026